Component

Human sclerostin / SOST

Context-specific entity; species, compartment and exposure are stated on each claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Strontium exposure decreased sclerostin protein expression in primary human osteoblast cultures in the 2011 study.

    Strontium ion / Sr2+ → Human sclerostin / SOST source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human primary osteoblast culture.
    limitations
    Separate from the Akt branch; an earlier long-term culture report found increased SOST mRNA with an osteocyte-like phenotype. Protein, RNA, stage and time are not interchangeable.
    nutrient_topic
    Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
    plain_language
    Removing a Wnt inhibitor can favor a bone-cell response.
    primary_references
    An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21566129/ · DOI 10.1074/jbc.M111.251116

    Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 174–180

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human primary osteoblast culture. · source_derived_draft · unverified_draft

    ## strontium-human-sclerostin Removing a Wnt inhibitor can favor a bone-cell response. Strontium exposure decreased sclerostin protein expression in primary human osteoblast cultures in the 2011 study. Model: Human primary osteoblast culture. Limitations: Separate from the Akt branch; an earlier long-term culture report found increased SOST mRNA with an osteocyte-like phenotype. Protein, RNA, stage and time are not interchangeable. Evidence access: Primary abstract An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21566129/ · DOI 10.1074/jbc.M111.251116
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Strontium ranelate induced an osteocyte-like phenotype, increased DMP1 and sclerostin mRNA and markedly increased mineralization at reported concentrations of 5 mM or greater.

    Strontium ranelate → Osteocyte-like phenotype in strontium-treated human cultures source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Long-term adult human primary osteoblast cultures.
    limitations
    High culture concentration; SOST transcript increase is not a direct contradiction of a different study measuring sclerostin protein.
    nutrient_topic
    Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
    plain_language
    Cell maturity and exposure can change which markers rise.
    primary_references
    Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. · 2009 · https://pubmed.ncbi.nlm.nih.gov/18763010/ · DOI 10.1007/s00198-008-0728-6

    Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 206–212

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Long-term adult human primary osteoblast cultures. · source_derived_draft · unverified_draft

    ## strontium-human-maturation Cell maturity and exposure can change which markers rise. Strontium ranelate induced an osteocyte-like phenotype, increased DMP1 and sclerostin mRNA and markedly increased mineralization at reported concentrations of 5 mM or greater. Model: Long-term adult human primary osteoblast cultures. Limitations: High culture concentration; SOST transcript increase is not a direct contradiction of a different study measuring sclerostin protein. Evidence access: Primary abstract Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. · 2009 · https://pubmed.ncbi.nlm.nih.gov/18763010/ · DOI 10.1007/s00198-008-0728-6
    Complete structured claim and evidence

  2. Strontium increased mineralization in primary human osteoblast cultures in the 2011 study.

    Strontium ion / Sr2+ → Mineralization in strontium-treated human osteoblast cultures source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Primary human osteoblast mineralization assay.
    limitations
    Later rat primary-culture work directly challenged a general mineralization-promoting interpretation; matched exposure and culture comparisons remain necessary.
    nutrient_topic
    Strontium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Strontium
    plain_language
    This study found more mineral deposition in its culture system.
    primary_references
    An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21566129/ · DOI 10.1074/jbc.M111.251116

    Strontium: calcium interactions, cellular mechanisms and mineralization (2026-09-19) · lines 190–196

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Primary human osteoblast mineralization assay. · source_derived_draft · unverified_draft

    ## strontium-human-mineralization-positive This study found more mineral deposition in its culture system. Strontium increased mineralization in primary human osteoblast cultures in the 2011 study. Model: Primary human osteoblast mineralization assay. Limitations: Later rat primary-culture work directly challenged a general mineralization-promoting interpretation; matched exposure and culture comparisons remain necessary. Evidence access: Primary abstract An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21566129/ · DOI 10.1074/jbc.M111.251116
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards